Acta otorrinolaringologica espanola · 2026
Supraglottic CO2 laser laryngectomy: Real-world outcomes from a single-institution cohort.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chiesa-Estomba Carlos M, Landa-Garmendia Maria, Rodriguez-Urzay Alfonso, Vargas-Alvarez Aitor, Larruscain-Sarasola Ekhiñe, González-García Jose A, Andueza-Guembe Maider, Sistaga-Suarez Jon A
Аннотация
INTRODUCTION: Supraglottic laryngeal cancers often present at advanced stages and carry poorer prognoses than glottic tumors. Transoral CO₂ laser microsurgery (TOLMS) offers a minimally invasive, organ-preserving alternative, but functional morbidity remains a challenge.
MATERIALS & METHODS: To evaluate oncological and functional outcomes of supraglottic partial CO₂ laser laryngectomy in a single-institution. Thirty-six patients treated with supraglottic partial CO₂ laser laryngectomy were analyzed retrospectively. Demographic, clinical, surgical, oncological, and functional outcomes were reviewed. Survival was analyzed using Kaplan-Meier estimates, and differences were tested with the log-rank test.
RESULTS: Mean age was 64 ± 8 years, with 83.3% male patients. Most tumors were pT2 (47.2%). Free surgical margins were achieved in 69.4% of cases. Three-year overall and disease-specific survival rates were 63.9% and 69.4%, respectively. Persistent gastrostomy dependence was observed in 3 (8.3%) patients. Tracheostomy was required in 4 (11.1%) patients, with persistent tracheostomy required in just 1 (2.8%) patient.
CONCLUSIONS: Supraglottic partial CO₂ laser laryngectomy offers oncologic outcomes comparable to published series. However, functional morbidity remains significant and warrants careful patient selection and preoperative counseling.
MATERIALS & METHODS: To evaluate oncological and functional outcomes of supraglottic partial CO₂ laser laryngectomy in a single-institution. Thirty-six patients treated with supraglottic partial CO₂ laser laryngectomy were analyzed retrospectively. Demographic, clinical, surgical, oncological, and functional outcomes were reviewed. Survival was analyzed using Kaplan-Meier estimates, and differences were tested with the log-rank test.
RESULTS: Mean age was 64 ± 8 years, with 83.3% male patients. Most tumors were pT2 (47.2%). Free surgical margins were achieved in 69.4% of cases. Three-year overall and disease-specific survival rates were 63.9% and 69.4%, respectively. Persistent gastrostomy dependence was observed in 3 (8.3%) patients. Tracheostomy was required in 4 (11.1%) patients, with persistent tracheostomy required in just 1 (2.8%) patient.
CONCLUSIONS: Supraglottic partial CO₂ laser laryngectomy offers oncologic outcomes comparable to published series. However, functional morbidity remains significant and warrants careful patient selection and preoperative counseling.